Coronary microvascular disease: the next frontier for Cardiovascular Research

Berry, C. and Duncker, D. J. (2020) Coronary microvascular disease: the next frontier for Cardiovascular Research. Cardiovascular Research, 116(4), pp. 737-740. (doi: 10.1093/cvr/cvaa035) (PMID:32149331) (PMCID:PMC7061275)

Abstract

No abstract available.

• Item Type: Articles (Editorial)
• Keywords: Physiology (medical), physiology, cardiology and cardiovascular medicine.
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: Berry, Professor Colin
• Authors: Berry, C., and Duncker, D. J.
• College/School: College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
• Journal Name: Cardiovascular Research
• Publisher: Oxford University Press
• ISSN: 0008-6363
• ISSN (Online): 1755-3245
• Published Online: 09 March 2020
• Copyright Holders: Copyright © 2020 The Authors
• First Published: First published in Cardiovascular Research 116(4): 737-740
• Publisher Policy: Reproduced in accordance with the publisher copyright policy

Project Code	Award No	Project Name	Principal Investigator	Funder's Name	Funder Ref	Lead Dept
174109		The conundrum of angina in patients without obstructive coronary disease: a randomised controlled pilot trial of routine testing of coronary function.	Colin Berry	British Heart Foundation (BHF)	FS/17/26/32744	Institute of Cardiovascular & Medical Sciences
303944		BHF Centre of Excellence	Rhian Touyz	British Heart Foundation (BHF)	RE/18/6/34217	CAMS - Cardiovascular Science
303684		A randomized, double-blind, placebo-controlled Phase 2A cross-over trial of oral zibotentan in patients with angina due to small vessel disease: a proof-of-concept, developmental trial for safety, efficacy and biomarkers development	Colin Berry	Medical Research Council (MRC)	MR/S018905/1	CAMS - Cardiovascular Science